Breaking News Instant updates and real-time market news.

NOVS

Novus Capital Corp.

$11.48 /

+0.195 (+1.73%)

08:41
10/26/20
10/26
08:41
10/26/20
08:41

AppHarvest breaks ground on third high-tech greenhouse in Appalachia

AppHarvest announced it has started construction on a third high-tech controlled environment agriculture facility in Central Appalachia and is expanding into growing leafy greens. Located in Berea, KY, the farm, when complete, will be 15 acres. The indoor facility will grow non-GMO, chemical pesticide-free leafy greens to be distributed to U.S. grocers and restaurants. Because of the company's strategic location in Appalachia, AppHarvest can reach nearly 70% of Americans in just a day's drive, reducing transportation costs by up to 80% compared to existing growers. American production is concentrated in Arizona and California, which combine to grow 90% of US-grown leafy greens.1 These states are in the midst of a decades-long drought and are consuming precious water resources. By contrast, Central Appalachia, where AppHarvest is investing in building controlled environment agriculture facilities, has an abundance of rain. The facility in Berea, like AppHarvest's other controlled environment agriculture facilities, will be designed to have its water needs met entirely by recycled rainwater using a closed-loop irrigation system where all water not absorbed by the plants is cleaned using sand and UV and then reused. The facility will continue to expand AppHarvest's growing space in Central Appalachia. AppHarvest opened its flagship farm - a 2.76-million-square-foot facility growing tomatoes - last week in nearby Morehead, KY and also broke ground for a second facility of similar size in Madison County outside Richmond, KY. In just over two years, AppHarvest has attracted more than $150 million in investment into Central Appalachia and announced on September 29 a definitive agreement for a business combination with publicly-traded special purpose acquisition company Novus Capital Corporation. The combination, which is expected to close late in the fourth quarter of 2020 or early in the first quarter of 2021, will provide $475 million of gross proceeds to the company, including $375 million fully committed common stock PIPE at $10.00 per share anchored by existing and new investors - including Fidelity Management & Research Company, LLC, Inclusive Capital, and Novus Capital Corporation. Upon closing of the transaction, the combined company will be named AppHarvest and is expected to remain listed on Nasdaq under the ticker symbol APPH.

TODAY'S FREE FLY STORIES

Earnings
Nicolet Bankshares reports Q4 EPS $1.74, consensus $1.49  16:03
01/19/21
01/19
16:03
01/19/21
16:03
NCBS

Nicolet Bankshares

$71.90 /

-0.39 (-0.54%)

 
ShowHide Related Items >><<
NCBS Nicolet Bankshares
$71.90 /

-0.39 (-0.54%)

NCBS Nicolet Bankshares
$71.90 /

-0.39 (-0.54%)

10/23/20 Maxim
Nicolet Bankshares price target raised to $77 from $70 at Maxim
10/09/20 Stephens
Stephens starts Nicolet Bankshares at Equal Weight, citing valuation
10/09/20 Stephens
Nicolet Bankshares initiated with an Equal Weight at Stephens
NCBS Nicolet Bankshares
$71.90 /

-0.39 (-0.54%)

Earnings
Interactive Brokers reports Q4 adjusted EPS 69c, consensus 59c » 16:03
01/19/21
01/19
16:03
01/19/21
16:03
IBKR

Interactive Brokers

$69.75 /

+0.68 (+0.98%)

Reports Q4 revenue $599M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IBKR Interactive Brokers
$69.75 /

+0.68 (+0.98%)

IBKR Interactive Brokers
$69.75 /

+0.68 (+0.98%)

01/05/21 Compass Point
Interactive Brokers price target raised to $65 from $62 at Compass Point
01/04/21 Goldman Sachs
Interactive Brokers growth still firing on all cylinders, says Goldman Sachs
12/02/20
Fly Intel: Top five analyst upgrades
12/02/20 Compass Point
Interactive Brokers upgraded to Buy with $62 price target at Compass Point
IBKR Interactive Brokers
$69.75 /

+0.68 (+0.98%)

IBKR Interactive Brokers
$69.75 /

+0.68 (+0.98%)

IBKR Interactive Brokers
$69.75 /

+0.68 (+0.98%)

IBKR Interactive Brokers
$69.75 /

+0.68 (+0.98%)

Earnings
Netflix sees Q1 EPS $2.97, consensus $2.10 » 16:03
01/19/21
01/19
16:03
01/19/21
16:03
NFLX

Netflix

$501.84 /

+3.89 (+0.78%)

Sees Q1 revenue $7.13B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$501.84 /

+3.89 (+0.78%)

NFLX Netflix
$501.84 /

+3.89 (+0.78%)

10:13 Today JPMorgan
JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'
01/15/21 Citi
Citi cuts Spotify to Sell with no benefit seen on podcast investments
01/15/21 Piper Sandler
Netflix search index suggests in-line Q4 subscriber results, says Piper Sandler
01/14/21 Barclays
Netflix could add 90M Asia-Pacific subs in five years, says Barclays
NFLX Netflix
$501.84 /

+3.89 (+0.78%)

NFLX Netflix
$501.84 /

+3.89 (+0.78%)

NFLX Netflix
$501.84 /

+3.89 (+0.78%)

NFLX Netflix
$501.84 /

+3.89 (+0.78%)

Syndicate
Syros Pharmaceuticals files to sell common stock, no amount given » 16:02
01/19/21
01/19
16:02
01/19/21
16:02
SYRS

Syros Pharmaceuticals

$14.91 /

+0.8 (+5.67%)

Cowen and Piper Sandler…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SYRS Syros Pharmaceuticals
$14.91 /

+0.8 (+5.67%)

SYRS Syros Pharmaceuticals
$14.91 /

+0.8 (+5.67%)

11/10/20 Brookline
Syros Pharmaceuticals initiated with a Buy at Brookline
11/05/20 Roth Capital
Syros' SY-1425+Aza could be competitive in multiple settings, says Roth Capital
11/04/20
Fly Intel: Top five analyst upgrades
11/04/20 H.C. Wainwright
Syros Pharmaceuticals upgraded to Buy from Neutral at H.C. Wainwright
SYRS Syros Pharmaceuticals
$14.91 /

+0.8 (+5.67%)

SYRS Syros Pharmaceuticals
$14.91 /

+0.8 (+5.67%)

Hot Stocks
Netflix reports Q4 global streaming paid net additions of 8.51M » 16:02
01/19/21
01/19
16:02
01/19/21
16:02
NFLX

Netflix

$501.84 /

+3.89 (+0.78%)

Netflix said in its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$501.84 /

+3.89 (+0.78%)

NFLX Netflix
$501.84 /

+3.89 (+0.78%)

10:13 Today JPMorgan
JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'
01/15/21 Citi
Citi cuts Spotify to Sell with no benefit seen on podcast investments
01/15/21 Piper Sandler
Netflix search index suggests in-line Q4 subscriber results, says Piper Sandler
01/14/21 Barclays
Netflix could add 90M Asia-Pacific subs in five years, says Barclays
NFLX Netflix
$501.84 /

+3.89 (+0.78%)

NFLX Netflix
$501.84 /

+3.89 (+0.78%)

NFLX Netflix
$501.84 /

+3.89 (+0.78%)

NFLX Netflix
$501.84 /

+3.89 (+0.78%)

Syndicate
Perion Network files to sell $50M in common stock » 16:02
01/19/21
01/19
16:02
01/19/21
16:02
PERI

Perion Network

$13.87 /

+0.855 (+6.57%)

Oppenheimer & Co.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PERI Perion Network
$13.87 /

+0.855 (+6.57%)

PERI Perion Network
$13.87 /

+0.855 (+6.57%)

01/04/21 Lake Street
Perion Network price target raised to $18 from $12 at Lake Street
12/31/20 Sidoti
Perion Network price target raised to $14 from $12 at Sidoti
11/19/20
Fly Intel: Top five analyst initiations
11/19/20 Roth Capital
Perion Network initiated with a Buy at Roth Capital
PERI Perion Network
$13.87 /

+0.855 (+6.57%)

PERI Perion Network
$13.87 /

+0.855 (+6.57%)

Syndicate
Fulcrum Therapeutics files to sell common stock, no amount given » 16:01
01/19/21
01/19
16:01
01/19/21
16:01
FULC

Fulcrum Therapeutics

$11.78 /

+0.84 (+7.68%)

SVB Leerink, Piper…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FULC Fulcrum Therapeutics
$11.78 /

+0.84 (+7.68%)

FULC Fulcrum Therapeutics
$11.78 /

+0.84 (+7.68%)

10/15/20 Piper Sandler
Fulcrum Therapeutics initiated with an Overweight at Piper Sandler
08/12/20
Fly Intel: Top five analyst downgrades
08/12/20 BTIG
Fulcrum Therapeutics price target lowered to $22 from $27 at BTIG
08/12/20 Morgan Stanley
Fulcrum Therapeutics downgraded at Morgan Stanley, price target slashed to $11
FULC Fulcrum Therapeutics
$11.78 /

+0.84 (+7.68%)

FULC Fulcrum Therapeutics
$11.78 /

+0.84 (+7.68%)

Syndicate
Aclaris Therapeutics files to sell common stock, no amount given » 16:01
01/19/21
01/19
16:01
01/19/21
16:01
ACRS

Aclaris Therapeutics

$18.23 /

+12.37 (+211.09%)

Cantor Fitzgerald &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACRS Aclaris Therapeutics
$18.23 /

+12.37 (+211.09%)

ACRS Aclaris Therapeutics
$18.23 /

+12.37 (+211.09%)

12:01 Today William Blair
Aclaris has potential in range of 'blockbuster indications,' says William Blair
ACRS Aclaris Therapeutics
$18.23 /

+12.37 (+211.09%)

ACRS Aclaris Therapeutics
$18.23 /

+12.37 (+211.09%)

Earnings
Netflix reports Q4 EPS $1.19, consensus $1.39 » 16:01
01/19/21
01/19
16:01
01/19/21
16:01
NFLX

Netflix

$502.50 /

+4.55 (+0.91%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$502.50 /

+4.55 (+0.91%)

NFLX Netflix
$502.50 /

+4.55 (+0.91%)

10:13 Today JPMorgan
JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'
01/15/21 Citi
Citi cuts Spotify to Sell with no benefit seen on podcast investments
01/15/21 Piper Sandler
Netflix search index suggests in-line Q4 subscriber results, says Piper Sandler
01/14/21 Barclays
Netflix could add 90M Asia-Pacific subs in five years, says Barclays
NFLX Netflix
$502.50 /

+4.55 (+0.91%)

NFLX Netflix
$502.50 /

+4.55 (+0.91%)

NFLX Netflix
$502.50 /

+4.55 (+0.91%)

NFLX Netflix
$502.50 /

+4.55 (+0.91%)

Periodicals
Facebook has no plans to lift Trump's account suspension, NBC News says » 15:49
01/19/21
01/19
15:49
01/19/21
15:49
FB

Facebook

$261.73 /

+10.2 (+4.06%)

Facebook does not have…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FB Facebook
$261.73 /

+10.2 (+4.06%)

FB Facebook
$261.73 /

+10.2 (+4.06%)

10:13 Today JPMorgan
JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'
09:52 Today
Fly Intel: Top five analyst upgrades
07:28 Today KeyBanc
Facebook price target raised to $345 from $340 at KeyBanc
05:02 Today BMO Capital
Facebook upgraded to Outperform from Market Perform at BMO Capital
FB Facebook
$261.73 /

+10.2 (+4.06%)

FB Facebook
$261.73 /

+10.2 (+4.06%)

FB Facebook
$261.73 /

+10.2 (+4.06%)

FB Facebook
$261.73 /

+10.2 (+4.06%)

Options
JinkoSolar call volume above normal and directionally bullish » 15:45
01/19/21
01/19
15:45
01/19/21
15:45
JKS

JinkoSolar

$63.18 /

+5.18 (+8.93%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JKS JinkoSolar
$63.18 /

+5.18 (+8.93%)

JKS JinkoSolar
$63.18 /

+5.18 (+8.93%)

01/04/21 Goldman Sachs
JinkoSolar price target raised to $39 from $34 at Goldman Sachs
12/30/20 GLJ Research
GLJ Research keeps Sell on JinkoSolar after chairman, CEO dump shares
12/21/20 Roth Capital
ITC/PTC extensions likely included in COVID relief package, says Roth Capital
12/15/20 Roth Capital
Solar tax credit extension would be positive surprise, says Roth Capital
JKS JinkoSolar
$63.18 /

+5.18 (+8.93%)

JKS JinkoSolar
$63.18 /

+5.18 (+8.93%)

JKS JinkoSolar
$63.18 /

+5.18 (+8.93%)

JKS JinkoSolar
$63.18 /

+5.18 (+8.93%)

Options
Interactive Brokers options imply 2.7% move in share price post-earnings » 15:34
01/19/21
01/19
15:34
01/19/21
15:34
IBKR

Interactive Brokers

$69.76 /

+0.69 (+1.00%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IBKR Interactive Brokers
$69.76 /

+0.69 (+1.00%)

IBKR Interactive Brokers
$69.76 /

+0.69 (+1.00%)

01/05/21 Compass Point
Interactive Brokers price target raised to $65 from $62 at Compass Point
01/04/21 Goldman Sachs
Interactive Brokers growth still firing on all cylinders, says Goldman Sachs
12/02/20
Fly Intel: Top five analyst upgrades
12/02/20 Compass Point
Interactive Brokers upgraded to Buy with $62 price target at Compass Point
IBKR Interactive Brokers
$69.76 /

+0.69 (+1.00%)

IBKR Interactive Brokers
$69.76 /

+0.69 (+1.00%)

IBKR Interactive Brokers
$69.76 /

+0.69 (+1.00%)

Hot Stocks
Carnival CEO sells over 62,000 common shares » 15:33
01/19/21
01/19
15:33
01/19/21
15:33
CCL

Carnival

$20.95 /

+0.155 (+0.75%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CCL Carnival
$20.95 /

+0.155 (+0.75%)

CCL Carnival
$20.95 /

+0.155 (+0.75%)

01/12/21 Deutsche Bank
Carnival price target raised to $16 from $13 at Deutsche Bank
10/30/20 Stifel
CDC lifting 'no sail order' a 'clear positive' for cruise liners, says Stifel
10/16/20 Deutsche Bank
Deutsche sees Covid newsflow remaining drag on cruise stocks
10/07/20 JPMorgan
Royal Caribbean price target raised to $79 from $67 at JPMorgan
CCL Carnival
$20.95 /

+0.155 (+0.75%)

  • 02
    Apr
CCL Carnival
$20.95 /

+0.155 (+0.75%)

CCL Carnival
$20.95 /

+0.155 (+0.75%)

CCL Carnival
$20.95 /

+0.155 (+0.75%)

Hot Stocks
Carnival CFO sells over 49,000 common shares » 15:32
01/19/21
01/19
15:32
01/19/21
15:32
CCL

Carnival

$20.96 /

+0.165 (+0.79%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CCL Carnival
$20.96 /

+0.165 (+0.79%)

CCL Carnival
$20.96 /

+0.165 (+0.79%)

01/12/21 Deutsche Bank
Carnival price target raised to $16 from $13 at Deutsche Bank
10/30/20 Stifel
CDC lifting 'no sail order' a 'clear positive' for cruise liners, says Stifel
10/16/20 Deutsche Bank
Deutsche sees Covid newsflow remaining drag on cruise stocks
10/07/20 JPMorgan
Royal Caribbean price target raised to $79 from $67 at JPMorgan
CCL Carnival
$20.96 /

+0.165 (+0.79%)

  • 02
    Apr
CCL Carnival
$20.96 /

+0.165 (+0.79%)

CCL Carnival
$20.96 /

+0.165 (+0.79%)

CCL Carnival
$20.96 /

+0.165 (+0.79%)

Recommendations
NN Group price target lowered to EUR 40 from EUR 41 at Barclays » 15:29
01/19/21
01/19
15:29
01/19/21
15:29
NNGRY

NN Group

$0.00 /

+ (+0.00%)

Barclays analyst Claudia…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NNGRY NN Group
$0.00 /

+ (+0.00%)

14:54 Today Morgan Stanley
NN Group price target raised to EUR 40.40 from EUR 36.90 at Morgan Stanley
01/06/21 Deutsche Bank
NN Group downgraded to Hold from Buy at Deutsche Bank
11/24/20 Barclays
NN Group price target raised to EUR 41 from EUR 40 at Barclays
11/12/20 Morgan Stanley
NN Group price target raised to EUR 36.90 from EUR 35.60 at Morgan Stanley
On The Fly
Fly Insider: REV Group, Neurocrine Bio among week's notable insider trades » 15:26
01/19/21
01/19
15:26
01/19/21
15:26
ADPT

Adaptive Biotechnologies

$67.13 /

+2.2 (+3.39%)

, REVG

REV Group

$10.64 /

+1.52 (+16.67%)

, CCEL

Cryo-Cell

$0.00 /

+ (+0.00%)

, SPLP

Steel Partners

$13.78 /

+0.43 (+3.22%)

, RILY

B. Riley Financial

$48.82 /

-0.84 (-1.69%)

, FB

Facebook

$261.66 /

+10.13 (+4.03%)

, NBIX

Neurocrine

$108.28 /

+0.37 (+0.34%)

, ONEM

1Life Healthcare

$47.03 /

+4.385 (+10.28%)

 Welcome to "Fly…

ShowHide Related Items >><<
ADPT Adaptive Biotechnologies
$67.13 /

+2.2 (+3.39%)

REVG REV Group
$10.64 /

+1.52 (+16.67%)

SPLP Steel Partners
$13.78 /

+0.43 (+3.22%)

RILY B. Riley Financial
$48.82 /

-0.84 (-1.69%)

FB Facebook
$261.66 /

+10.13 (+4.03%)

NBIX Neurocrine
$108.28 /

+0.37 (+0.34%)

ONEM 1Life Healthcare
$47.03 /

+4.385 (+10.28%)

ADPT Adaptive Biotechnologies
$67.13 /

+2.2 (+3.39%)

06:48 Today BTIG
Adaptive Biotechnologies price target raised to $74 from $66 at BTIG
12/17/20 BTIG
BTIG positive on select healthcare diagnostic/tools names as '2021 Top Picks'
11/12/20 BTIG
Adaptive Biotechnologies price target raised to $63 from $60 at BTIG
11/11/20 JPMorgan
Adaptive Biotechnologies price target raised to $60 from $50 at JPMorgan
REVG REV Group
$10.64 /

+1.52 (+16.67%)

01/08/21 Baird
REV Group result pretty much as expected, says Baird
12/17/20 Baird
REV Q4 results delay could portend impending portfolio realignment, says Baird
12/15/20 Morgan Stanley
REV Group upgraded to Equal Weight on improved RV outlook at Morgan Stanley
12/15/20 Morgan Stanley
REV Group upgraded to Equal Weight from Underweight at Morgan Stanley
CCEL Cryo-Cell
$0.00 /

+ (+0.00%)

SPLP Steel Partners
$13.78 /

+0.43 (+3.22%)

RILY B. Riley Financial
$48.82 /

-0.84 (-1.69%)

FB Facebook
$261.66 /

+10.13 (+4.03%)

10:13 Today JPMorgan
JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'
09:52 Today
Fly Intel: Top five analyst upgrades
07:28 Today KeyBanc
Facebook price target raised to $345 from $340 at KeyBanc
05:02 Today BMO Capital
Facebook upgraded to Outperform from Market Perform at BMO Capital
NBIX Neurocrine
$108.28 /

+0.37 (+0.34%)

12/29/20 Cantor Fitzgerald
Neurocrine price target lowered to $121 from $168 at Cantor Fitzgerald
12/07/20 Wedbush
Neurocrine price target lowered to $121 from $129 at Wedbush
11/12/20 Canaccord
Neurocrine price target lowered to $122 from $145 at Canaccord
11/10/20 SVB Leerink
Neurocrine price target lowered to $100 from $120 at SVB Leerink
ONEM 1Life Healthcare
$47.03 /

+4.385 (+10.28%)

10:07 Today JPMorgan
Teladoc remains top 2021 healthcare technology pick at JPMorgan
01/08/21 Piper Sandler
1Life Healthcare price target raised to $51 from $44 at Piper Sandler
01/07/21 Canaccord
1Life Healthcare price target raised to $50 from $46 at Canaccord
01/06/21 BTIG
1Life Healthcare initiated with a Neutral at BTIG
ADPT Adaptive Biotechnologies
$67.13 /

+2.2 (+3.39%)

REVG REV Group
$10.64 /

+1.52 (+16.67%)

SPLP Steel Partners
$13.78 /

+0.43 (+3.22%)

RILY B. Riley Financial
$48.82 /

-0.84 (-1.69%)

FB Facebook
$261.66 /

+10.13 (+4.03%)

NBIX Neurocrine
$108.28 /

+0.37 (+0.34%)

ONEM 1Life Healthcare
$47.03 /

+4.385 (+10.28%)

  • 13
    Jan
  • 23
    Nov
  • 16
    Jul
  • 25
    Jun
  • 31
    Jan
  • 24
    Jan
FB Facebook
$261.66 /

+10.13 (+4.03%)

ADPT Adaptive Biotechnologies
$67.13 /

+2.2 (+3.39%)

REVG REV Group
$10.64 /

+1.52 (+16.67%)

RILY B. Riley Financial
$48.82 /

-0.84 (-1.69%)

FB Facebook
$261.66 /

+10.13 (+4.03%)

NBIX Neurocrine
$108.28 /

+0.37 (+0.34%)

ONEM 1Life Healthcare
$47.03 /

+4.385 (+10.28%)

FB Facebook
$261.66 /

+10.13 (+4.03%)

ONEM 1Life Healthcare
$47.03 /

+4.385 (+10.28%)

Recommendations
Icade price target lowered to EUR 67 from EUR 68 at Barclays » 15:25
01/19/21
01/19
15:25
01/19/21
15:25
CDMGF

Icade

$0.00 /

+ (+0.00%)

Barclays analyst Celine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CDMGF Icade
$0.00 /

+ (+0.00%)

11/09/20 Goldman Sachs
Icade upgraded to Neutral from Sell at Goldman Sachs
10/23/20 Deutsche Bank
Icade price target lowered to EUR 74 from EUR 99 at Deutsche Bank
10/20/20 BofA
Icade upgraded to Buy from Neutral at BofA
09/03/20 Morgan Stanley
Icade price target lowered to EUR 60 from EUR 75 at Morgan Stanley
On The Fly
Lumentum slides after announcing $5.7B merger deal with Coherent » 15:22
01/19/21
01/19
15:22
01/19/21
15:22
LITE

Lumentum

$95.61 /

-10.58 (-9.96%)

, COHR

Coherent

$199.54 /

+47.62 (+31.35%)

, AAPL

Apple

$128.05 /

+0.98 (+0.77%)

Shares of Lumentum (LITE)…

ShowHide Related Items >><<
LITE Lumentum
$95.61 /

-10.58 (-9.96%)

COHR Coherent
$199.54 /

+47.62 (+31.35%)

AAPL Apple
$128.05 /

+0.98 (+0.77%)

LITE Lumentum
$95.61 /

-10.58 (-9.96%)

14:54 Today Craig-Hallum
Lumentum acquisition of Coherent 'a good fit in many ways,' says Craig-Hallum
01/12/21 MKM Partners
Lumentum price target raised to $138 from $120 at MKM Partners
01/12/21 Susquehanna
Susquehanna names top five M&A candidates in Semi space
01/11/21 B. Riley Securities
Lumentum price target raised to $123 from $101 at B. Riley Securities
COHR Coherent
$199.54 /

+47.62 (+31.35%)

14:54 Today Craig-Hallum
Lumentum acquisition of Coherent 'a good fit in many ways,' says Craig-Hallum
01/12/21 Barclays
Coherent downgraded to Underweight from Equal Weight at Barclays
11/12/20 Longbow
Coherent downgraded to Neutral ahead of transition year at Longbow
11/12/20 Longbow
Coherent downgraded to Neutral from Buy at Longbow
AAPL Apple
$128.05 /

+0.98 (+0.77%)

14:54 Today Craig-Hallum
Lumentum acquisition of Coherent 'a good fit in many ways,' says Craig-Hallum
05:02 Today BMO Capital
Facebook upgraded to Outperform from Market Perform at BMO Capital
01/15/21 Goldman Sachs
Goldman Sachs raises short-term forecasts for Apple, maintains Sell rating
01/15/21 Loop Capital
Apple price target raised to $155 from $131 at Loop Capital
LITE Lumentum
$95.61 /

-10.58 (-9.96%)

COHR Coherent
$199.54 /

+47.62 (+31.35%)

AAPL Apple
$128.05 /

+0.98 (+0.77%)

LITE Lumentum
$95.61 /

-10.58 (-9.96%)

COHR Coherent
$199.54 /

+47.62 (+31.35%)

AAPL Apple
$128.05 /

+0.98 (+0.77%)

LITE Lumentum
$95.61 /

-10.58 (-9.96%)

COHR Coherent
$199.54 /

+47.62 (+31.35%)

AAPL Apple
$128.05 /

+0.98 (+0.77%)

LITE Lumentum
$95.61 /

-10.58 (-9.96%)

AAPL Apple
$128.05 /

+0.98 (+0.77%)

Recommendations
Galapagos price target raised to $125 from $85.50 at Barclays » 15:21
01/19/21
01/19
15:21
01/19/21
15:21
GLPG

Galapagos

$107.48 /

+7.48 (+7.48%)

Barclays analyst Emily…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GLPG Galapagos
$107.48 /

+7.48 (+7.48%)

GLPG Galapagos
$107.48 /

+7.48 (+7.48%)

05:55 Today Morgan Stanley
Galapagos upgraded to Overweight from Equal Weight at Morgan Stanley
12/18/20 Truist
Gilead price target lowered to $62 from $67 at Truist
12/17/20 Maxim
Galapagos price target lowered to $140 from $170 at Maxim
12/17/20 Oppenheimer
Gilead price target lowered to $100 from $105 at Oppenheimer
GLPG Galapagos
$107.48 /

+7.48 (+7.48%)

GLPG Galapagos
$107.48 /

+7.48 (+7.48%)

Periodicals
India requests that WhatsApp pull privacy policy update, Reuters says » 15:21
01/19/21
01/19
15:21
01/19/21
15:21
FB

Facebook

$261.44 /

+9.91 (+3.94%)

India's Ministry of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FB Facebook
$261.44 /

+9.91 (+3.94%)

FB Facebook
$261.44 /

+9.91 (+3.94%)

10:13 Today JPMorgan
JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'
09:52 Today
Fly Intel: Top five analyst upgrades
07:28 Today KeyBanc
Facebook price target raised to $345 from $340 at KeyBanc
05:02 Today BMO Capital
Facebook upgraded to Outperform from Market Perform at BMO Capital
FB Facebook
$261.44 /

+9.91 (+3.94%)

FB Facebook
$261.44 /

+9.91 (+3.94%)

FB Facebook
$261.44 /

+9.91 (+3.94%)

FB Facebook
$261.44 /

+9.91 (+3.94%)

Options
Call seller writes $35M notional block at six month term » 15:20
01/19/21
01/19
15:20
01/19/21
15:20
SLV

iShares Silver Trust

$23.34 /

+0.39 (+1.70%)

Call seller writes $35M…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SLV iShares Silver Trust
$23.34 /

+0.39 (+1.70%)

SLV iShares Silver Trust
$23.34 /

+0.39 (+1.70%)

Options
J B Hunt Transport Services options imply 5.8% move in share price post-earnings » 15:19
01/19/21
01/19
15:19
01/19/21
15:19
JBHT

J.B. Hunt

$148.78 /

-2.87 (-1.89%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JBHT J.B. Hunt
$148.78 /

-2.87 (-1.89%)

JBHT J.B. Hunt
$148.78 /

-2.87 (-1.89%)

06:10 Today Credit Suisse
J.B. Hunt upgraded to Outperform from Neutral at Credit Suisse
01/06/21 Citi
J.B. Hunt upgraded to Buy from Neutral at Citi
01/05/21 Stephens
J.B. Hunt price target raised to $167 from $155 at Stephens
11/30/20 Deutsche Bank
J.B. Hunt price target raised to $139 from $132 at Deutsche Bank
JBHT J.B. Hunt
$148.78 /

-2.87 (-1.89%)

JBHT J.B. Hunt
$148.78 /

-2.87 (-1.89%)

JBHT J.B. Hunt
$148.78 /

-2.87 (-1.89%)

Hot Stocks
Surgical Directions announces management buyout deal with Mednax » 15:19
01/19/21
01/19
15:19
01/19/21
15:19
MD

Mednax

$23.98 /

+0.39 (+1.65%)

Surgical Directions…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MD Mednax
$23.98 /

+0.39 (+1.65%)

MD Mednax
$23.98 /

+0.39 (+1.65%)

01/05/21 Truist
Mednax price target raised to $26 from $20 at Truist
10/19/20
Fly Intel: Top five analyst downgrades
10/19/20 Deutsche Bank
Mednax downgraded to Sell from Hold at Deutsche Bank
06/09/20 Mizuho
Mednax price target raised to $20 from $17 at Mizuho
MD Mednax
$23.98 /

+0.39 (+1.65%)

MD Mednax
$23.98 /

+0.39 (+1.65%)

Recommendations
ConvaTec price target raised to 250 GBp from 245 GBp at Barclays » 15:18
01/19/21
01/19
15:18
01/19/21
15:18
CNVVY

ConvaTec

$0.00 /

+ (+0.00%)

Barclays analyst Hassan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CNVVY ConvaTec
$0.00 /

+ (+0.00%)

01/04/21 JPMorgan
ConvaTec upgraded to Neutral from Underweight at JPMorgan
12/09/20 Morgan Stanley
ConvaTec price target lowered to 208 GBp from 210 GBp at Morgan Stanley
11/18/20 Morgan Stanley
ConvaTec price target raised to 210 GBp from 200 GBp at Morgan Stanley
10/29/20 JPMorgan
ConvaTec price target raised to 176 GBp from 175 GBp at JPMorgan
Recommendations
Coca-Cola Femsa price target raised to $50 from $45 at Barclays » 15:17
01/19/21
01/19
15:17
01/19/21
15:17
KOF

Coca-Cola Femsa

$46.80 /

-0.81 (-1.70%)

Barclays analyst Benjamin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KOF Coca-Cola Femsa
$46.80 /

-0.81 (-1.70%)

07/13/20 Barclays
Coca-Cola Femsa downgraded on South American exposure at Barclays
07/13/20 Barclays
Coca-Cola Femsa downgraded to Equal Weight from Overweight at Barclays
06/09/20 Itau BBA
Coca-Cola Femsa upgraded to Outperform from Market Perform at Itau BBA
04/24/20 Scotiabank
Coca-Cola Femsa downgraded to Sector Perform from Outperform at Scotiabank

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.